
AVITA Medical RCEL
€ 4.16
-2.62%
Geschäftsbericht 2025
hinzugefügt 12.02.2026
AVITA Medical Langfristige Verbindlichkeiten 2011-2026 | RCEL
Langfristige Verbindlichkeiten Jährlich AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 2.35 M | 466 K | 98.7 K | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.35 M | 98.7 K | 972 K |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 12.51 | -3.81 % | $ 1.88 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
Electromed
ELMD
|
8.87 K | $ 24.39 | 0.41 % | $ 206 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 38.81 | 0.81 % | $ 5.78 K | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.47 | -0.32 % | $ 121 M | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 8.35 | 1.89 % | $ 600 M | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 9.45 | -2.28 % | $ 1.28 B | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
InMode Ltd.
INMD
|
12.5 M | $ 13.44 | -0.9 % | $ 869 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
CONMED Corporation
CNMD
|
877 M | $ 41.7 | -3.0 % | $ 1.29 B | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.17 | -1.97 % | $ 155 M | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
1.61 M | $ 28.69 | -1.81 % | $ 1.32 B | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.22 | -2.42 % | $ 111 M | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Pulmonx Corporation
LUNG
|
25 M | $ 1.64 | 13.89 % | $ 64.1 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
196 M | $ 0.52 | -0.29 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Medtronic PLC
MDT
|
29.6 B | $ 93.07 | -2.65 % | $ 120 B | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.81 | 2.33 % | $ 44.1 M | ||
|
Align Technology
ALGN
|
184 M | $ 174.77 | -4.06 % | $ 13.1 B | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 110.75 | -2.08 % | $ 193 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.54 | -4.15 % | $ 149 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Orthofix Medical
OFIX
|
83.1 M | $ 12.5 | -2.87 % | $ 495 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 71.01 | -1.66 % | $ 105 B | ||
|
IRadimed Corporation
IRMD
|
4.76 M | $ 101.75 | -3.2 % | $ 1.29 B | ||
|
PAVmed
PAVM
|
300 K | $ 10.4 | -1.0 % | $ 75.2 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.42 | 0.71 % | $ 22.9 M | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.73 | -4.06 % | $ 416 M |